Increased skin carcinogenesis in caspase-activated DNase knockout mice

Carcinogenesis

Volumn 30, Issue 10, 2009, Pages 1776-1780

  Yan, Bin ^a,b   Wang, Huili ^b   Xie, Donghua ^b   Wakamatsu, Nobuko ^c   Anscher, Mitchell S ^a   Dewhirst, Mark W ^b   Mitchel, Ron E J ^d   Chen, Benny J ^b   Li, Chuan Yuan ^b,e  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d ATOMIC ENERGY OF CANADA LIMITED   (Canada)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE ACTIVATED DEOXYRIBONUCLEASE; DIMETHYLBENZ[A]ANTHRACENE; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME LOCALIZATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SKIN CARCINOGENESIS; SKIN PAPILLOMA; TUMOR VOLUME; WILD TYPE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; APOPTOSIS; CONSERVED SEQUENCE; CROSSES, GENETIC; DEOXYRIBONUCLEASES; DNA; DNA FRAGMENTATION; DNA PRIMERS; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOPLASM STAGING; NUCLEOSOMES; SKIN NEOPLASMS;

EID: 70349993597     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp146     Document Type: Article

References (17)

1. Liu,X. et al. (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell, 89, 175-184.
2. Enari,M. et al. (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature, 391, 43-50.
3. Lechardeur,D. et al. (2000) Determinants of the nuclear localization of the heterodimeric DNA fragmentation factor (ICAD/CAD). J. Cell Biol., 150, 321-334.
4. Yan,B. et al. (2006) A unique role of the DNA fragmentation factor in maintaining genomic stability. Proc. Natl Acad. Sci. USA, 103, 1504-1509.
5. Yan,B. et al. (2006) Apoptotic DNA fragmentation factor maintains chromosome stability in a P53-independent manner. Oncogene, 25 5370-5376.
6. Maris,J.M. et al. (1995) Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Cancer Res., 55, 4664-4669.
7. Van Gele,M. et al. (1998) Characteristic pattern of chromosomal gains and losses in Merkel cell carcinoma detected by comparative genomic hybridization. Cancer Res., 58, 1503-1508.
8. Schwab,M. et al. (1996) Genomic instability in 1p and human malignancies. Genes Chromosomes Cancer, 16, 211-229.
9. Abel,F. et al. (2002) Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours. Br. J. Cancer, 86, 596-604.
10. Konishi,S. et al. (2002) Decreased expression of DFF45/ICAD is correlated with a poor prognosis in patients with esophageal carcinoma. Cancer, 95, 2473-2478.
11. Ohira,M. et al. (2000) Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line. Oncogene, 19, 4302-4307.
12. Abel,F. et al. (2004) Mutations in the N-terminal domain of DFF45 in a primary germ cell tumor and in neuroblastoma tumors. Int. J. Oncol., 25, 1297-1302.
13. Kawane,K. et al. (2003) Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation. Nat. Immunol., 4, 138-144.
14. Sakahira,H. et al. (1998) Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature, 391 96-99.
15. Rodriguez-Villanueva,J. et al. (1998) Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation. Oncogene, 16, 853-863.
16. Jansen,B.J. et al. (2003) Tumor necrosis factor related apoptosis inducing ligand triggers apoptosis in dividing but not in differentiating human epidermal keratinocytes. J. Invest. Dermatol. 121, 1433-1439.
17. Brown,K. et al. (1990) Carcinogen-induced mutations in the mouse cHa- ras gene provide evidence of multiple pathways for tumor progression. Proc. Natl Acad. Sci. USA, 87, 538-542.